Search results
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 5 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more...
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women s Health· 3 days agoA new set of COVID-19 variants—which have been given the nickname FLiRT—are the new dominant strain in the United States, currently accounting for 28.2% of all cases, the ...
What to Know: FLiRT COVID-19 Variants Spreading in the U.S.
US News & World Report· 4 days agoA group of COVID-19 variants nicknamed “FLiRT” is spreading as the U.S. heads into summer. JN.1 was the top strain circulating in the U.S. for much of the winter. KP.2 was ...
Spokesperson: Gun discharged by patient amid security incident at Bristol hospital
Bristol Herald Courier· 2 days agoBRISTOL, Tenn.--Local law enforcement responded to Bristol Regional Medical Center on Wednesday...
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
WKRN Nashville· 14 hours agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Gresham’s Law Comes for Science | naked capitalism
Naked Capitalism· 3 days agoScience publication has become so corrupted that entire journals have been shut down over running fake research. How did we get here?
New study provides the "definitive answer on masks." They work.
Boing Boing· 15 hours agoThe paper, which is based on a narrative review and meta-analysis research project, was written by...
Mystery Finally Solved? New Discovery Could Explain Long COVID
SciTechDaily· 5 days agoResearchers at UVA Health have uncovered a potential explanation for some of the most puzzling...
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
KTLA-TV Los Angeles· 2 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
The Kansas City Star· 2 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...